AQR Capital Management
GH icon

AQR Capital Management’s Guardant Health GH Stock Holding History

AQR Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3M Sell
121,668
-9,630
-7% -$1.05M 0.01% 1231
2026
Q1 		$12.1M Buy
131,298
+32,425
+33% +$3.26M 0.01% 1246
2025
Q4 		$10.1M Buy
98,873
+17,296
+21% +$1.55M 0.01% 1212
2025
Q3 		$5.1M Buy
81,577
+1,446
+2% +$78.7K ﹤0.01% 1446
2025
Q2 		$4.17M Buy
80,131
+8,597
+12% +$384K ﹤0.01% 1386
2025
Q1 		$3.01M Buy
71,534
+25,831
+57% +$1.11M ﹤0.01% 1376
2024
Q4 		$1.4M Buy
45,703
+33,268
+268% +$936K ﹤0.01% 1711
2024
Q3 		$285K Buy
+12,435
New +$352K ﹤0.01% 2417
2024
Q1 		– Sell
-26,817
Closed -$725K – 2442
2023
Q4 		$725K Buy
26,817
+905
+3% +$23.7K ﹤0.01% 1726
2023
Q3 		$768K Sell
25,912
-64,567
-71% -$2.27M ﹤0.01% 1696
2023
Q2 		$3.24M Buy
+90,479
New +$2.6M 0.01% 1082
2023
Q1 		– Sell
-13,418
Closed -$351K – 2201
2022
Q4 		$351K Buy
+13,418
New +$614K ﹤0.01% 1925
2021
Q3 		– Sell
-22,351
Closed -$2.78M – 2268
2021
Q2 		$2.78M Sell
22,351
-2,740
-11% -$369K ﹤0.01% 1049
2021
Q1 		$3.73M Sell
25,091
-2,890
-10% -$437K 0.01% 899
2020
Q4 		$3.52M Sell
27,981
-11,129
-28% -$1.28M 0.01% 899
2020
Q3 		$4.35M Buy
39,110
+143
+0.4% +$13.1K 0.01% 812
2020
Q2 		$3.11M Buy
38,967
+15,927
+69% +$1.28M 0.01% 966
2020
Q1 		$1.6M Buy
+23,040
New +$1.77M ﹤0.01% 1155

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

AQR Capital Management's GH Position: Q2 2026 in Review

AQR Capital Management reduced its Guardant Health (GH) stake by 7.3% in Q2 2026, selling an estimated $1.05M and leaving 121,668 shares worth $18.3M. The position accounts for 0.01% of the portfolio, ranked #1231.

AQR Capital Management first reported a position in GH in Q1 2020 and has held it in 18 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • AQR Capital Management held 121,668 shares of Guardant Health worth $18.3M as of Q2 2026.
  • AQR Capital Management sold 9,630 Guardant Health shares in Q2 2026, an estimated $1.05M.
  • Guardant Health made up 0.01% of AQR Capital Management's portfolio in Q2 2026, its #1231 holding.
  • AQR Capital Management first reported a position in Guardant Health in Q1 2020 and has held it in 18 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.